SCOTTISH Health Innovations Limited (SHIL) recognises the achievements of NHS employees with a prestigious award which is presented to the winner at the annual Scottish Enterprise Life Sciences Awards ceremony.
Although this award is open to all health boards in Scotland, Greater Glasgow and Clyde has a tremendous track record in winning this award more times than any other health board. In the eight years that this award has been presented, NHSGGC have been the recipient on five occasions.
Looking back at the previous recipients of this award, it is clear that NHSGGC has created an environment that cultivates innovative practices. The Multifocal ERG is currently on the market and is distributed in several European countries while the Epilepsy Alarm is licensed to a company that continues to develop the technology. Aurum is a spinout company set up by SHIL to advance the GOLD technology with further investment.
SHIL works in partnership with NHS Scotland to protect and develop new innovations that come from healthcare professionals. By developing these ideas, SHIL creates new products and technologies that will improve patient care and generate income for NHS Scotland.
The 2013 shortlist for the Best Innovation Originating from the NHS will be announced in December.
Find out more about the previous winners of SHIL’s prestigious award below.
2013: Aurum and its GOLD Technology
Celestine Santosh and Dave Brennan are part of a team which has developed a new technology using a novel oxygen carrier and proprietary software for use with MRI, initially for Acute Ischaemic Stroke known as AIS. Currently in preclinical development Gold simultaneously provides improved imaging of damaged brain tissue and delivers oxygen to prevent further tissue damage and tissue death.
2011: Epilepsy Alarm
Dr. Aline Russell, Dr. Renga Radhakrishnan and Dr. Stig Hansen were part of a team responsible for the development of a novel epilepsy alarm. Epaware is a potentially life-saving product that detects the movement associated tonic-clonic seizures and incorporates a new pattern recognition electronic algorithm to improve sensitivity in the real time detection of movement associated with motor seizure.
Su Stenhouse, Victoria Murday and Daniel Ellis developed the Glasgow Linkage-Exclusion Analysis Method (GLEAM) which is an analysis tool that allows the possible determination or narrowing down of the pathogenic cause of some heterogenous genetic disease using a phenomenon known as genetic linkage.
2007: Multifocal ERG
Based at Gartnavel Hospital Dr David Keating and Dr Stuart Parks of the Tennent Institute of Ophthalmology invented a multifocal electrophysiology system to examine the function of the cells within the retina. This technique may pick up early signs of disease and changes within the eye at a very early stage.
2006: Ultrasound Probe
Dr Malcolm Watson, an anaesthetist from NHSGGC developed a new ultrasound method which will allow a safer procedure for administration of epidural anaesthesia during labour.
If you would like advice on any aspect of innovation, contact the Research & Development Management Office, NHS Greater Glasgow and Clyde, The Tennent Institute, Western Infirmary, 38 Church Street, Glasgow, G11 6NT or SHIL, email: email@example.com or tel: 0141 201 4750.